{"paper_id":"47e4f06d-8b0e-4dee-921b-6d66381babf2","body_text":"MULTIMODAL TREATMENT STRATEGIES IN ENDOMETRIOSIS: A CONTEMPORARY SYSTEMATIC REVIEW OF MEDICAL AND SURGICAL MANAGEMENT\nDOI:\nhttps://doi.org/10.31435/ijitss.4(48).2025.4506Keywords:\nEndometriosis, GnRH Antagonists, Pharmacotherapy, Postoperative Management, Assisted Reproductive Technologies, Multimodal CareAbstract\nIntroduction: Endometriosis is a chronic, estrogen-dependent disorder characterized by ectopic endometrial-like tissue, chronic pelvic pain and impaired fertility. Optimal management requires balancing symptom control, recurrence prevention and preservation of reproductive potential. This review synthesizes evidence on contemporary pharmacological, postoperative and non-pharmacological strategies to inform multidisciplinary care.\nMethodology: A literature review of PubMed, Scopus, and Google Scholar was performed, focusing on recent systematic reviews and meta-analyses evaluating surgical, pharmacological, non-pharmacological, and assisted reproductive strategies for endometriosis.\nResults: Progestogens (notably dienogest) and continuous/extended COCs reduce dysmenorrhea and chronic pelvic pain and serve as viable long-term maintenance. Oral GnRH antagonists provide rapid, dose-dependent analgesia with add-back strategies mitigating hypoestrogenic harms. Surgical excision may yield superior symptom relief and lower recurrence in selected phenotypes but risks ovarian reserve loss, tissue-paring techniques can attenuate this effect. Postoperative hormonal suppression (≥6–12 months) reduces recurrence. Integrated non-pharmacological modalities improve pain coping, adherence and HRQoL. Endometriomas and deep disease negatively affect ovarian response and implantation, supporting individualized pre-ART planning\nConclusion: Effective endometriosis management requires an individualized, multimodal approach integrating surgery, medical therapy, supportive care, and fertility planning. Holistic strategies enhance quality of life, reduce pain, and optimize reproductive outcomes. Interdisciplinary coordination is key to tailoring therapy according to patient phenotype, reproductive goals, and disease severity.\nReferences\nZakhari, A., Delpero, E., McKeown, S., Tomlinson, G., Bougie, O., & Murji, A. (2021). Endometriosis recurrence following post-operative hormonal suppression: a systematic review and meta-analysis. Human reproduction update, 27(1), 96–107. https://doi.org/10.1093/humupd/dmaa033\nLiu, Y., Gong, H., Gou, J., Liu, X., & Li, Z. (2021). Dienogest as a Maintenance Treatment for Endometriosis Following Surgery: A Systematic Review and Meta-Analysis. Frontiers in medicine, 8, 652505. https://doi.org/10.3389/fmed.2021.652505\nWu, H., Liu, J. J., Ye, S. T., Liu, J., & Li, N. (2024). Efficacy and safety of dienogest in the treatment of deep infiltrating endometriosis: A meta-analysis. European journal of obstetrics, gynecology, and reproductive biology, 297, 40–49. https://doi.org/10.1016/j.ejogrb.2024.03.032\nXin, L., Ma, Y., Ye, M., Chen, L., Liu, F., & Hou, Q. (2023). Efficacy and safety of oral gonadotropin-releasing hormone antagonists in moderate-to-severe endometriosis-associated pain: a systematic review and network meta-analysis. Archives of gynecology and obstetrics, 308(4), 1047–1056. https://doi.org/10.1007/s00404-022-06862-0\nDelanerolle, G., Ramakrishnan, R., Hapangama, D., Zeng, Y., Shetty, A., Elneil, S., Chong, S., Hirsch, M., Oyewole, M., Phiri, P., Elliot, K., Kothari, T., Rogers, B., Sandle, N., Haque, N., Pluchino, N., Silem, M., O'Hara, R., Hull, M. L., Majumder, K., … Raymont, V. (2021). A systematic review and meta-analysis of the Endometriosis and Mental-Health Sequelae; The ELEMI Project. Women's health (London, England), 17, 17455065211019717. https://doi.org/10.1177/17455065211019717\nDel Pino-Sedeño, T., Cabrera-Maroto, M., Abrante-Luis, A., González-Hernández, Y., & Ortíz Herrera, M. C. (2024). Effectiveness of psychological interventions in endometriosis: a systematic review with meta-analysis. Frontiers in psychology, 15, 1457842. https://doi.org/10.3389/fpsyg.2024.1457842\nWang, J. Y., Zhang, Y., & Ding, J. (2025). Oral Gonadotropin-Releasing Hormone Antagonists in the Treatment of Endometriosis: Advances in Research. Journal of clinical medicine research, 17(6), 299–308. https://doi.org/10.14740/jocmr6236\nSomigliana, E., Li Piani, L., Paffoni, A., Salmeri, N., Orsi, M., Benaglia, L., Vercellini, P., & Vigano', P. (2023). Endometriosis and IVF treatment outcomes: unpacking the process. Reproductive biology and endocrinology : RB&E, 21(1), 107. https://doi.org/10.1186/s12958-023-01157-8\nMappa, I., Page, Z. P., Di Mascio, D., Patelli, C., D'Antonio, F., Giancotti, A., Gebbia, F., Mariani, G., Cozzolino, M., Muzii, L., & Rizzo, G. (2024). The Effect of Endometriosis on In Vitro Fertilization Outcomes: A Systematic Review and Meta-Analysis. Healthcare (Basel, Switzerland), 12(23), 2435. https://doi.org/10.3390/healthcare12232435\nQing, X., He, L., Ma, Y., Zhang, Y., & Zheng, W. (2024). Systematic review and meta-analysis on the effect of adjuvant gonadotropin-releasing hormone agonist (GnRH-a) on pregnancy outcomes in women with endometriosis following conservative surgery. BMC pregnancy and childbirth, 24(1), 237. https://doi.org/10.1186/s12884-024-06430-1\nMitchell, J. B., Chetty, S., & Kathrada, F. (2022). Progestins in the symptomatic management of endometriosis: a meta-analysis on their effectiveness and safety. BMC women's health, 22(1), 526. https://doi.org/10.1186/s12905-022-02122-0\nMuzii, L., Di Tucci, C., Galati, G., Carbone, F., Palaia, I., Bogani, G., Perniola, G., Tomao, F., Kontopantelis, E., & Di Donato, V. (2023). The Efficacy of Dienogest in Reducing Disease and Pain Recurrence After Endometriosis Surgery: a Systematic Review and Meta-Analysis. Reproductive sciences (Thousand Oaks, Calif.), 30(11), 3135–3143. https://doi.org/10.1007/s43032-023-01266-0\nPiacenti, I., Tius, V., Viscardi, M. F., Biasioli, A., Arcieri, M., Restaino, S., Muzii, L., Vizzielli, G., & Porpora, M. G. (2025). Dienogest vs. combined oral contraceptive: A systematic review and meta-analysis of efficacy and side effects to inform evidence-based guidelines. Acta obstetricia et gynecologica Scandinavica, 104(8), 1424–1432. https://doi.org/10.1111/aogs.15145\nBrown, J., Crawford, T. J., Datta, S., & Prentice, A. (2018). Oral contraceptives for pain associated with endometriosis. The Cochrane database of systematic reviews, 5(5), CD001019. https://doi.org/10.1002/14651858.CD001019.pub3\nCooper, K. G., Bhattacharya, S., Daniels, J. P., Horne, A. W., Clark, T. J., Saridogan, E., Cheed, V., Pirie, D., Melyda, M., Monahan, M., Roberts, T. E., Cox, E., Stubbs, C., Middleton, L. J., & PRE-EMPT Collaborative Group (2024). Long acting progestogens versus combined oral contraceptive pill for preventing recurrence of endometriosis related pain: the PRE-EMPT pragmatic, parallel group, open label, randomised controlled trial. BMJ (Clinical research ed.), 385, e079006. https://doi.org/10.1136/bmj-2023-079006\nCsirzó, Á., Kovács, D. P., Szabó, A., Szabó, B., Jankó, Á., Hegyi, P., Nyirády, P., Ács, N., & Valent, S. (2024). Comparative Analysis of Medical Interventions to Alleviate Endometriosis-Related Pain: A Systematic Review and Network Meta-Analysis. Journal of clinical medicine, 13(22), 6932. https://doi.org/10.3390/jcm13226932\nDonnez, J., Becker, C., Taylor, H., Carmona Herrera, F., Donnez, O., Horne, A., Paszkowski, M., Petraglia, F., Renner, S. P., Patel, A., Boolell, M., Bestel, E., & Dolmans, M. M. (2024). Linzagolix therapy versus a placebo in patients with endometriosis-associated pain: a prospective, randomized, double-blind, Phase 3 study (EDELWEISS 3). Human reproduction (Oxford, England), 39(6), 1208–1221. https://doi.org/10.1093/humrep/deae076\nGiudice, L. C., As-Sanie, S., Arjona Ferreira, J. C., Becker, C. M., Abrao, M. S., Lessey, B. A., Brown, E., Dynowski, K., Wilk, K., Li, Y., Mathur, V., Warsi, Q. A., Wagman, R. B., & Johnson, N. P. (2022). Once daily oral relugolix combination therapy versus placebo in patients with endometriosis-associated pain: two replicate phase 3, randomised, double-blind, studies (SPIRIT 1 and 2). Lancet (London, England), 399(10343), 2267–2279. https://doi.org/10.1016/S0140-6736(22)00622-5\nMiller, C. E., Kim, J. H., Kroll, R., Simon, J. A., Soliman, A. M., Thomas, J. W., Xu, Y., Ng, J., & Snabes, M. C. (2024). Efficacy, tolerability, and bone density outcomes of elagolix with add-back therapy for endometriosis-associated pain: twelve months of an ongoing randomized phase 3 trial. American journal of obstetrics and gynecology, 231(6), 630.e1–630.e13. https://doi.org/10.1016/j.ajog.2024.06.040\nDonnez, J., Petraglia, F., Taylor, H., Becker, C., Becker, S., Carmona Herrera, F., Paszkowski, M., Bestel, E., Hori, S., & Dolmans, M. M. (2025). Two-year follow-up study (PRIMROSE 3) to assess bone mineral density in subjects with uterine fibroids completing the PRIMROSE 1 and PRIMROSE 2 linzagolix trials. Human reproduction open, 2025(3), hoaf025. https://doi.org/10.1093/hropen/hoaf025\nBecker, C. M., Johnson, N. P., As-Sanie, S., Arjona Ferreira, J. C., Abrao, M. S., Wilk, K., Imm, S. J., Mathur, V., Perry, J. S., Wagman, R. B., & Giudice, L. C. (2024). Two-year efficacy and safety of relugolix combination therapy in women with endometriosis-associated pain: SPIRIT open-label extension study. Human reproduction (Oxford, England), 39(3), 526–537. https://doi.org/10.1093/humrep/dead263\nPundir, J., Omanwa, K., Kovoor, E., Pundir, V., Lancaster, G., & Barton-Smith, P. (2017). Laparoscopic Excision Versus Ablation for Endometriosis-associated Pain: An Updated Systematic Review and Meta-analysis. Journal of minimally invasive gynecology, 24(5), 747–756. https://doi.org/10.1016/j.jmig.2017.04.008\nBurks, C., Lee, M., DeSarno, M., Findley, J., & Flyckt, R. (2021). Excision versus Ablation for Management of Minimal to Mild Endometriosis: A Systematic Review and Meta-analysis. Journal of minimally invasive gynecology, 28(3), 587–597. https://doi.org/10.1016/j.jmig.2020.11.028\nHashemi, M., Rouholamin, S., Ghahiri, A., & Momeni Alkami, F. (2023). Comparison of laparoscopic ablation versus excision for superficial endometriosis-associated pain. American Journal of Clinical and Experimental Obstetrics & Gynecology, 9(1), 1-7. https://e-century.us/files/ajceog/9/1/ajceog0148677.pdf\nWattanayingcharoenchai, R., Rattanasiri, S., Charakorn, C., Attia, J., & Thakkinstian, A. (2021). Postoperative hormonal treatment for prevention of endometrioma recurrence after ovarian cystectomy: a systematic review and network meta-analysis. BJOG : an international journal of obstetrics and gynaecology, 128(1), 25–35. https://doi.org/10.1111/1471-0528.16366\nXiong, Y., Huang, W., Wang, C., Ma, W., Jin, S., Lin, J., Deng, X., Peng, Y., Huang, Y., Du, X., & Han, X. (2025). Effectiveness and Safety of Postoperative Medical Treatments Following Fertility-Preserving Surgery for Endometriosis: A Network Meta-Analysis. BJOG : an international journal of obstetrics and gynaecology, 10.1111/1471-0528.70016. Advance online publication. https://doi.org/10.1111/1471-0528.70016\nSkhirtladze, D., Kristesashvili, J., & Charekishvili, R. (2024). Efficacy of postsurgical medical therapy for infertile patients with deep endometriosis. Ginekologia polska, 10.5603/gpl.99414. Advance online publication. https://doi.org/10.5603/gpl.99414\nChen, I., Veth, V. B., Choudhry, A. J., Murji, A., Zakhari, A., Black, A. Y., Agarpao, C., & Maas, J. W. (2020). Pre- and postsurgical medical therapy for endometriosis surgery. The Cochrane database of systematic reviews, 11(11), CD003678. https://doi.org/10.1002/14651858.CD003678.pub3\nJiang, D., Zhang, X., Shi, J., Tao, D., & Nie, X. (2021). Risk factors for ovarian endometrioma recurrence following surgical excision: a systematic review and meta‑analysis. Archives of gynecology and obstetrics, 304(3), 589–598. https://doi.org/10.1007/s00404-021-06129-0\nVeth, V. B., Keukens, A., Reijs, A., Bongers, M. Y., Mijatovic, V., Coppus, S. F. P. J., & Maas, J. W. M. (2024). Recurrence after surgery for endometrioma: a systematic review and meta-analyses. Fertility and sterility, 122(6), 1079–1093. https://doi.org/10.1016/j.fertnstert.2024.07.033\nKeukens, A., Veth, V. B., Regis, M., Mijatovic, V., Bongers, M. Y., Coppus, S. F. P. J., & Maas, J. W. M. (2024). The effect of surgery or medication on pain and quality of life in women with endometrioma. A systematic review and meta-analysis. European journal of obstetrics, gynecology, and reproductive biology, 293, 95–105. https://doi.org/10.1016/j.ejogrb.2023.12.012\nHodgson, R. M., Lee, H. L., Wang, R., Mol, B. W., & Johnson, N. (2020). Interventions for endometriosis-related infertility: a systematic review and network meta-analysis. Fertility and sterility, 113(2), 374–382.e2. https://doi.org/10.1016/j.fertnstert.2019.09.031\nRichard, E., Morin, J., Murji, A., Lemyre, M., Laberge, P. Y., & Maheux-Lacroix, S. (2022). Effect of Postoperative Hormonal Suppression on Fertility in Patients With Endometriosis After Conservative Surgery: A Systematic Review and Meta-analysis. Obstetrics and gynecology, 139(6), 1169–1179. https://doi.org/10.1097/AOG.0000000000004811\nDesai, J., Strong, S., & Ball, E. (2024). Holistic approaches to living well with endometriosis. F1000Research, 13, 359. https://doi.org/10.12688/f1000research.142586.2\nGiese, N., Kwon, K. K., & Armour, M. (2023). Acupuncture for endometriosis: A systematic review and meta-analysis. Integrative medicine research, 12(4), 101003. https://doi.org/10.1016/j.imr.2023.101003\nLi, H., Wang, X., Wang, Y., Gao, Y., Zheng, X., Zhang, X., Li, X., Zheng, X., Fan, X., Zuo, G., & She, Y. (2024). Acupuncture and Related Therapies for Endometriosis: A Network Meta-Analysis of Randomized Controlled Trials. Journal of pain research, 17, 3197–3216. https://doi.org/10.2147/JPR.S488343\nChen, C., Li, X., Lu, S., Yang, J., & Liu, Y. (2024). Acupuncture for clinical improvement of endometriosis-related pain: a systematic review and meta-analysis. Archives of gynecology and obstetrics, 310(4), 2101–2114. https://doi.org/10.1007/s00404-024-07675-z\nXie, M., Qing, X., Huang, H., Zhang, L., Tu, Q., Guo, H., & Zhang, J. (2025). The effectiveness and safety of physical activity and exercise on women with endometriosis: A systematic review and meta-analysis. PloS one, 20(2), e0317820. https://doi.org/10.1371/journal.pone.0317820\nCan, G., Amorim das Virgens, I. P., Fehér, B., Orbán, E. P., Fehérvári, P., Bánhidy, F., Hegyi, P., Mayer, Á. A., & Ács, N. (2025). Physiotherapy for endometriosis-associated pelvic pain: A systematic review and meta-analysis. Pain medicine (Malden, Mass.), pnaf083. Advance online publication. https://doi.org/10.1093/pm/pnaf083\nMick, I., Freger, S. M., van Keizerswaard, J., Gholiof, M., & Leonardi, M. (2024). Comprehensive endometriosis care: a modern multimodal approach for the treatment of pelvic pain and endometriosis. Therapeutic advances in reproductive health, 18, 26334941241277759. https://doi.org/10.1177/26334941241277759\nFang, Q. Y., Campbell, N., Mooney, S. S., Holdsworth-Carson, S. J., & Tyson, K. (2024). Evidence for the role of multidisciplinary team care in people with pelvic pain and endometriosis: A systematic review. The Australian & New Zealand journal of obstetrics & gynaecology, 64(3), 181–192. https://doi.org/10.1111/ajo.13755\nMcReynolds, D., Shiraz, R., Tangey, M. A., Egerton, T., & Frawley, H. (2025). Effectiveness of Multidisciplinary Treatment Compared to Single Discipline Treatment of Female Chronic Pelvic Pain: A Systematic Review and Meta-Analyses. BJOG : an international journal of obstetrics and gynaecology, 132(12), 1716–1733. https://doi.org/10.1111/1471-0528.18322\nQu, H., Du, Y., Yu, Y., Wang, M., Han, T., & Yan, L. (2022). The effect of endometriosis on IVF/ICSI and perinatal outcome: A systematic review and meta-analysis. Journal of gynecology obstetrics and human reproduction, 51(9), 102446. https://doi.org/10.1016/j.jogoh.2022.102446\nLatif, S., Khanjani, S., & Saridogan, E. (2024). Endometriosis and In Vitro Fertilization. Medicina (Kaunas, Lithuania), 60(8), 1358. https://doi.org/10.3390/medicina60081358\nAlson, S., Henic, E., Jokubkiene, L., & Sladkevicius, P. (2024). Endometriosis diagnosed by ultrasound is associated with lower live birth rates in women undergoing their first in vitro fertilization/intracytoplasmic sperm injection treatment. Fertility and sterility, 121(5), 832–841. https://doi.org/10.1016/j.fertnstert.2024.01.023\nBecker, C. M., Bokor, A., Heikinheimo, O., Horne, A., Jansen, F., Kiesel, L., King, K., Kvaskoff, M., Nap, A., Petersen, K., Saridogan, E., Tomassetti, C., van Hanegem, N., Vulliemoz, N., Vermeulen, N., & ESHRE Endometriosis Guideline Group (2022). ESHRE guideline: endometriosis. Human reproduction open, 2022(2), hoac009. https://doi.org/10.1093/hropen/hoac009\nYounis, J. S., & Taylor, H. S. (2024). The impact of ovarian endometrioma and endometriotic cystectomy on anti-Müllerian hormone, and antral follicle count: a contemporary critical appraisal of systematic reviews. Frontiers in endocrinology, 15, 1397279. https://doi.org/10.3389/fendo.2024.1397279\nWu, C. Q., Albert, A., Alfaraj, S., Taskin, O., Alkusayer, G. M., Havelock, J., Yong, P., Allaire, C., & Bedaiwy, M. A. (2019). Live Birth Rate after Surgical and Expectant Management of Endometriomas after In Vitro Fertilization: A Systematic Review, Meta-Analysis, and Critical Appraisal of Current Guidelines and Previous Meta-Analyses. Journal of minimally invasive gynecology, 26(2), 299–311.e3. https://doi.org/10.1016/j.jmig.2018.08.029\nColombi, I., Ginetti, A., Cannoni, A., Cimino, G., d'Abate, C., Schettini, G., Giorgi, M., Raimondo, D., Martire, F. G., Lazzeri, L., Zupi, E., & Centini, G. (2024). Combine Surgery and In Vitro Fertilization (IVF) in Endometriosis-Related Infertility: When and Why. Journal of clinical medicine, 13(23), 7349. https://doi.org/10.3390/jcm13237349\nRiemma, G. (2025). Surgery prior to IVF/ICSI versus up-front IVF/ICSI for the treatment of infertility associated with ovarian and deep infiltrating endometriosis: A systematic review and meta-analysis. Reproductive BioMedicine Online, Article 105178. https://doi.org/10.1016/j.rbmo.2025.105178\nBourdon, M., Peigné, M., Maignien, C., de Villardi de Montlaur, D., Solignac, C., Darné, B., Languille, S., Bendifallah, S., & Santulli, P. (2024). Impact of Endometriosis Surgery on In Vitro Fertilization/Intracytoplasmic Sperm Injection Outcomes: a Systematic Review and Meta-analysis. Reproductive sciences (Thousand Oaks, Calif.), 31(6), 1431–1455. https://doi.org/10.1007/s43032-023-01421-7\nShao, W., Li, Y., & Wang, Y. (2023). Impact of dienogest pretreatment on IVF-ET outcomes in patients with endometriosis: a systematic review and meta-analysis. Journal of ovarian research, 16(1), 166. https://doi.org/10.1186/s13048-023-01245-8\nPublished\nIssue\nSection\nLicense\nAll articles are published in open-access and licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0). Hence, authors retain copyright to the content of the articles.\nCC BY 4.0 License allows content to be copied, adapted, displayed, distributed, re-published or otherwise re-used for any purpose including for adaptation and commercial use provided the content is attributed.","source_license":"CC0","license_restricted":false}